• 1. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Comprehensive Overview of (R)-3-((tert-Butoxycarbonyl)amino)-2-methylpropanoic Acid (CAS No. 132696-45-8)

(R)-3-((tert-Butoxycarbonyl)amino)-2-methylpropanoic Acid (CAS No. 132696-45-8) is a chiral organic compound widely utilized in pharmaceutical synthesis and biochemical research. This compound features a tert-butoxycarbonyl (Boc) protecting group, which is critical for peptide synthesis and drug development. Its unique stereochemistry and functional groups make it a valuable intermediate in the production of active pharmaceutical ingredients (APIs) and fine chemicals.

The growing demand for enantiomerically pure compounds in the pharmaceutical industry has increased the relevance of (R)-3-((tert-Butoxycarbonyl)amino)-2-methylpropanoic Acid. Researchers and manufacturers are particularly interested in its role in asymmetric synthesis, where chiral purity is essential for drug efficacy and safety. Recent advancements in green chemistry and sustainable synthesis methods have further highlighted the importance of this compound, as it aligns with the industry's shift toward environmentally friendly processes.

One of the most frequently searched topics related to CAS No. 132696-45-8 is its application in peptide coupling reactions. The Boc group in this compound serves as a temporary protecting group for amines, enabling selective reactions in multi-step syntheses. This property is particularly valuable in the development of biologics and small-molecule drugs, where precision and yield are paramount. Additionally, its stability under various conditions makes it a preferred choice for solid-phase peptide synthesis (SPPS).

Another area of interest is the compound's role in prodrug design. Prodrugs are biologically inactive compounds that convert into active drugs within the body, improving bioavailability and reducing side effects. The chiral center and carboxylic acid moiety in (R)-3-((tert-Butoxycarbonyl)amino)-2-methylpropanoic Acid make it a versatile building block for designing such prodrugs, addressing challenges in drug delivery and patient compliance.

From a commercial perspective, the global market for pharmaceutical intermediates is expanding rapidly, driven by the increasing prevalence of chronic diseases and the need for innovative therapies. (R)-3-((tert-Butoxycarbonyl)amino)-2-methylpropanoic Acid is positioned as a key player in this market, with suppliers and contract research organizations (CROs) offering custom synthesis services to meet diverse research and production needs.

In conclusion, (R)-3-((tert-Butoxycarbonyl)amino)-2-methylpropanoic Acid (CAS No. 132696-45-8) is a multifaceted compound with significant applications in modern drug discovery and development. Its compatibility with green chemistry principles, combined with its utility in peptide synthesis and prodrug design, ensures its continued relevance in the pharmaceutical and biotechnology sectors. As research progresses, this compound is likely to play an even greater role in addressing unmet medical needs and advancing therapeutic innovation.

• 518038-34-1(Carbamic acid, [(2R)-2-methyl-3-oxopropyl]-, 1,1-dimethylethyl ester (9CI))
• 16948-10-0(3-((Tert-Butoxycarbonyl)amino)-2-methylpropanoic acid)
• 12676-37-8(Deriphat 151 (9CI))
• 1158759-58-0(3-({[(tert-butoxy)carbonyl]amino}methyl)azetidine-3-carboxylic acid)
• 3303-84-2(Boc-β-Ala-OH)
• 190897-47-3((2S)-3-(tert-butoxycarbonylamino)-2-methyl-propanoic acid)
• 182486-32-4(Methyl 3-((tert-butoxycarbonyl)amino)-2-methylpropanoate)
• 180181-02-6(3-{[(tert-butoxy)carbonyl]amino}-2,2-dimethylpropanoic acid)
• 374729-55-2(Carbamic acid,N-[(2S)-2-methyl-3-oxopropyl]-, 1,1-dimethylethyl ester)
• 195387-08-7(Methyl 3-((tert-butoxycarbonyl)amino)-2,2-dimethylpropanoate)